Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Kallmann syndrome can cause eye issues and other health problems, requiring various treatments.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Hair loss and excessive growth treated with various options, including new laser technology.

Finasteride effectively treats baldness but may cause sexual side effects.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

The most common skin problems in polycystic ovarian disease are hirsutism and acne, and managing these symptoms is key for treatment.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

An older woman had false beliefs after taking a depression medication, which stopped when she stopped the medication.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Finasteride safely reduces excessive hair growth in women.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.